- Benzinga•7 days agoMuddy Waters' Carson Block: Announced Tech Fixes Do Not Appear To Address Many Of The Larger Problems For Abbott-St. Jude
In a new development in the feud between Muddy Waters Research and St Jude Medical Inc (previously traded (NYSE: STJ )), which involves patient safety in medical technology implants, the research firm ...
- The Wall Street Journal•7 days ago
Medtronic is facing new competition in supplying devices for deep brain stimulation, an established therapy for moderating the symptoms of Parkinson’s disease.
- Moody's•11 days ago
New York, January 05, 2017-- Moody's Investors Service, downgraded St. Jude Medical, Inc.' s senior unsecured note ratings to Baa3 from Baa2 following Abbott Laboratories' acquisition of St. Jude on January ...
STJ : Summary for St. Jude Medical, Inc. - Yahoo Finance
St. Jude Medical, Inc. (STJ)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Day's Range||0.00 - 0.00|
|52 Week Range|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||35.14|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|